The DOI matches its Crossref record.
Transrectal High-Intensity Focused Ultrasound: Minimally Invasive Therapy of Localized Prostate Cancer
Abstract
BACKGROUND AND PURPOSE: Criteria for determining the durability of the response to transrectal high-intensity focused ultrasound (HIFU) ablation of prostate cancer have been established by calculating progression-free probability. PATIENTS AND METHODS: A series of 82 patients (mean age 71 +/- 5.7 years) with biopsy-proven localized (stage T1-T2) cancer who were not suitable candidates for radical surgery underwent transfectal HIFU ablation with the Ablatherm machine. The mean follow-up was 17.6 months (range 3-68 months). The mean serum prostate specific antigen (PSA) value and mean prostate volume were 8.11 +/- 4.64 ng/mL and 34.9 +/- 17.4 cm3, respectively. Progression was rigidly defined as any positive biopsy result, regardless of PSA concentration, or three successive PSA increases for patients with a negative biopsy (PSA velocity > or = 0.75). Times to specific events (positive biopsy and PSA elevation) were analyzed with the Kaplan-Meier survival method. RESULTS: Overall, 62% of the patients exhibited no evidence of disease progression 60 months after transrectal HIFU ablation. In particular, the disease-free rate was 68% for the moderate-risk group of 50 patients (PSA < 15.0 ng/mL, Gleason sum < 8, prostate volume < 40 cm3, and number of positive biopsies < 5). For the low-risk group of 32 patients (PSA < 10 ng/mL and Gleason sum < 7), the disease-free survival rate was 83%. CONCLUSION: Transrectal HIFU prostate ablation is an effective therapeutic alternative for patients with localized prostatic adenocarcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
High intensity focused ultrasound: Physical principles and devices
ter Haar, >., & Coussios, C. (2007) · International Journal of Hyperthermia · doi:10.1080/02656730601186138 · Cited by 805
Overview of Therapeutic Ultrasound Applications and Safety Considerations
Miller, D. L., Smith, N. B., Bailey, M. R., Czarnota, G. J., Hynynen, K., Makin, I. R. S., & Bioeffects Committee of the American Institute of Ultrasound in Medicine (2012) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2012.31.4.623 · Cited by 752
Therapeutic applications of ultrasound
ter Haar, G. (2007) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2006.07.005 · Cited by 721
High intensity focused ultrasound: surgery of the future?
Kennedy, J. E., ter Haar, G. R., & Cranston, D. (2003) · The British Journal of Radiology · doi:10.1259/bjr/17150274 · Cited by 709
High intensity focused ultrasound in clinical tumor ablation
Zhou, Y.-F. (2011) · World Journal of Clinical Oncology · doi:10.5306/wjco.v2.i1.8 · Cited by 625
Wilt, T. J., MacDonald, R., Rutks, I., Shamliyan, T. A., Taylor, B. C., & Kane, R. L. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00209 · Cited by 597
High-Intensity Focused Ultrasound: Current Potential and Oncologic Applications
Dubinsky, T. J., Cuevas, C., Dighe, M. K., Kolokythas, O., & Hwang, J. H. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.2671 · Cited by 420
Skin cancer and new treatment perspectives: A review
Simões, M. C. F., Sousa, J. J. S., & Pais, A. A. C. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.001 · Cited by 414
High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience
Blana, A., Walter, B., Rogenhofer, S., & Wieland, W. F. (2004) · Urology · doi:10.1016/j.urology.2003.09.020 · Cited by 350
Wu, F., Wang, Z.-B., Zhu, H., Chen, W.-Z., Zou, J.-Z., Bai, J., Li, K.-Q., Jin, C.-B., Xie, F.-L., & Su, H.-B. (2005) · Radiology · doi:10.1148/radiol.2362041105 · Cited by 277
Low frequency nanobubble-enhanced ultrasound mechanotherapy for noninvasive cancer surgery
Bismuth, M., Katz, S., Mano, T., Aronovich, R., Hershkovitz, D., Exner, A. A., & Ilovitsh, T. (2022) · Nanoscale · doi:10.1039/d2nr01367c · Cited by 41
Metadata
- Authors
- GELET, A., CHAPELON, J. Y., BOUVIER, R., ROUVIÈRE, O., LASNE, Y., LYONNET, D., & DUBERNARD, J. M.
- Venue
- Journal of Endourology
- Publisher
- SAGE Publications
- Published
- 2000-08
- Volume
- 14
- Issue
- 6
- Pages
- 519-528
- ISSN
- 0892-7790 (ISSN-L)
- 1557-900X
- OpenAlex
- W2040538815
- Cited by
- 214
- References
- 0
- FWCI
- 10.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.